BCRX
#1860
BioCryst Pharmaceuticals, Inc. - Common Stock
9.7 4 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.72%
Variación mensual
+7.15%
Variación en los últimos 6 meses
+36.80%
Cambio anual
+11.31%
Cierres anteriores
9.9 1
Open
9.7 4
Mínimo
9.7 4
High
9.7 4
Volumen
148
Financials
- Market Capitalization 2.48 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.38
Relación precio/flujo de caja
2.4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1845 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.91 USD | +8.41% | -8.15% | +22.09% | +161.08% | 2.54 B USD | ||
| 1856 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.39 USD | +6.10% | -6.36% | +76.18% | +597.40% | 2.49 B USD | ||
| 1873 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.11 USD | -5.40% | -20.06% | -9.69% | -15.06% | 2.41 B USD | ||
| 1880 |  NRIX Nurix Therapeutics, Inc. - Common stock | 22.98 USD | +1.19% | -4.29% | +35.74% | +105.00% | 2.38 B USD |